Increasing anabolic potential but also hypertrophy risk in non-target tissues
doi: 10.3389/fmed.2021.790513
Metformin and semaglutide (Ozempic) represent two distinct approaches to managing weight and blood sugar: metformin works by reducing liver glucose production, while semaglutide activates GLP-1 receptors to slow gastric emptying and increase insulin secretion
Why does Wegovy cause diarrhea in some people and constipation in others
also an oral form Rybelsus ), Liraglutide ( Victoza for diabetes, Saxenda for weight loss), Dulaglutide ( Trulicity ), Exenatide ( Byetta short-acting, Bydureon long-acting), Lixisenatide ( Adlyxin ), and newer dual-agonist drugs like Tirzepatide ( Mounjaro ), which activates the GLP-1 receptor and the GIP receptor (another incretin hormone) All of these medications work in a similar physiological manner by leveraging the GLP-1 pathway to improve glycemic control and suppress appetite
Ultimately, individual assessments by healthcare providers are essential to determine the best approach for each patient
